BioSpace News Archive

Rehabilitation after knee replacement is an essential part of the recovery process.

Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines, announced that Pablo J. Cagnoni, M.D., chief executive officer, will present at Jefferies London Healthcare Conference Wednesday, November 20, 2019, at 10:00 a.m. GMT / 5:00 a.m. EST.

Align Technology, Inc. announced the opening of its 2020 Research Award Program to support clinical and scientific dental research in universities across the globe.

Equillium, Inc. announced financial results for the third quarter 2019 and recent business highlights.

HOOKIPA Pharma Inc., a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, reports its financial results for the third quarter ended September 30, 2019 and provides a corporate update.

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, reported financial results for the third quarter and nine months ended September 30, 2019, and provided a corporate update.

Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, today reported continuing growth and improved financial results for the quarter and nine-months ended September 30, 2019.

CABOMETYX™ slows disease progression and improves survival for patients with advanced liver canceri previously treated with sorafenibii

Additions support Obsidian’s active program development, operational build-out and ongoing regulatory discussions

AtriCure, Inc., a leading innovator in surgical treatments for atrial fibrillation and left atrial appendage management, announced that the company will be participating in the upcoming Piper Jaffray 31st Annual Healthcare Conference in New York City.